GEN Exclusives

More »

GEN News Highlights

More »
Jul 6, 2011

Unilabs to Offer Companion Diagnostic Services for Biogen Idec’s Tysabri

  • Biogen Idec has selected Unilabs to provide a companion diagnostic anti-JCV antibody assay test, called Stratify-JCV. The presence of anti-JCV antibodies is part of a three-factor risk stratification algorithm, along with prior immunosuppressant use and treatment duration, used to calculate the risk of Tysabri-treated patients developing progressive multifocal leukoencephalopathy (PML).

    The test is a two-step ELISA assay used to detect anti-JCV antibodies. To support customers, ordering needs, and volume of samples, Unilabs and Biogen Idec have also developed a closed web interface. This will allow neurologists to order sampling and shipping materials, register courier sample pick- up details, and request language and format of analytical reports. Also, neurologists can seek sampling, shipping, and medical support in five languages through a multilingual call center.

    The project is centralized to and managed by Unilabs in Copenhagen. “Unilabs is an independent commercial laboratory with a very high reputation, a strong European footprint, and excellent international skills, competences, and agility,” comments Natascha Schill, Biogen Idec.

    Unilabs says that it operates in over 100 laboratories and 30 radiology units in Europe. It serves hospitals, outpatients clinics, GPs, occupational health units, insurance companies, drug development companies, and CROs.

Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Patient Access to Genetic Information

Do you think patients have the absolute right to gain access to their own genetic information from medical or clinical laboratories?

More »